121 related articles for article (PubMed ID: 24716639)
1. Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan.
McDonald SA; Hutchinson SJ; Innes HA; Allen S; Bramley P; Bhattacharyya D; Carman W; Dillon JF; Fox R; Fraser A; Goldberg DJ; Kennedy N; Mills PR; Morris J; Stanley AJ; Wilks D; Hayes PC
J Viral Hepat; 2014 May; 21(5):366-76. PubMed ID: 24716639
[TBL] [Abstract][Full Text] [Related]
2. Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland.
McAllister G; Innes H; Mcleod A; Dillon JF; Hayes PC; Fox R; Barclay ST; Templeton K; Aitken C; Gunson R; Goldberg D; Hutchinson SJ
J Clin Virol; 2014 Nov; 61(3):359-64. PubMed ID: 25264306
[TBL] [Abstract][Full Text] [Related]
3. Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment.
Aspinall EJ; Hutchinson SJ; Janjua NZ; Grebely J; Yu A; Alavi M; Amin J; Goldberg DJ; Innes H; Law M; Walter SR; Krajden M; Dore GJ
J Hepatol; 2015 Feb; 62(2):269-77. PubMed ID: 25200903
[TBL] [Abstract][Full Text] [Related]
4. Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study.
Hansen N; Obel N; Christensen PB; Krarup H; Laursen AL; Clausen MR; Lunding S; Møller A; Schlichting P; Kromann-Andersen H; Bukh J; Weis N;
J Viral Hepat; 2009 Sep; 16(9):659-65. PubMed ID: 19486467
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect-acting antiviral era.
McDonald SA; Innes HA; Aspinall E; Hayes PC; Alavi M; Valerio H; Goldberg DJ; Hutchinson SJ
J Viral Hepat; 2017 Apr; 24(4):295-303. PubMed ID: 27885753
[TBL] [Abstract][Full Text] [Related]
7. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial.
Groessl EJ; Sklar M; Cheung RC; Bräu N; Ho SB
Contemp Clin Trials; 2013 Jul; 35(2):97-107. PubMed ID: 23669414
[TBL] [Abstract][Full Text] [Related]
8. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.
Mehta SH; Lucas GM; Mirel LB; Torbenson M; Higgins Y; Moore RD; Thomas DL; Sulkowski MS
AIDS; 2006 Nov; 20(18):2361-9. PubMed ID: 17117023
[TBL] [Abstract][Full Text] [Related]
9. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.
Alavi M; Grebely J; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S62-9. PubMed ID: 23884068
[TBL] [Abstract][Full Text] [Related]
10. Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study.
Alavi M; Micallef M; Fortier E; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ; Grebely J;
J Viral Hepat; 2015 Nov; 22(11):914-25. PubMed ID: 25996567
[TBL] [Abstract][Full Text] [Related]
11. Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testing.
McLeod A; Weir A; Aitken C; Gunson R; Templeton K; Molyneaux P; McIntyre P; McDonald S; Goldberg D; Hutchinson S
J Epidemiol Community Health; 2014 Dec; 68(12):1182-8. PubMed ID: 25170094
[TBL] [Abstract][Full Text] [Related]
12. Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.
John-Baptiste AA; Tomlinson G; Hsu PC; Krajden M; Heathcote EJ; Laporte A; Yoshida EM; Anderson FH; Krahn MD
Am J Gastroenterol; 2009 Oct; 104(10):2439-48. PubMed ID: 19568230
[TBL] [Abstract][Full Text] [Related]
13. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
[TBL] [Abstract][Full Text] [Related]
14. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
15. Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention.
Cullen BL; Hutchinson SJ; Cameron SO; Anderson E; Ahmed S; Spence E; Mills PR; Mandeville R; Forrest E; Washington M; Wong R; Fox R; Goldberg DJ
J Public Health (Oxf); 2012 Mar; 34(1):14-23. PubMed ID: 22138489
[TBL] [Abstract][Full Text] [Related]
16. Vitamin B12 supplementation improves rates of sustained viral response in patients chronically infected with hepatitis C virus.
Rocco A; Compare D; Coccoli P; Esposito C; Di Spirito A; Barbato A; Strazzullo P; Nardone G
Gut; 2013 May; 62(5):766-73. PubMed ID: 22810757
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
18. Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C.
Vermehren J; Yu ML; Monto A; Yao JD; Anderson C; Bertuzis R; Schneider G; Sarrazin C
J Clin Virol; 2011 Oct; 52(2):133-7. PubMed ID: 21803650
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions.
Winnock M; Bani-Sadr F; Pambrun E; Loko MA; Carrieri P; Neau D; Morlat P; Marchou B; Dabis F; Salmon D;
HIV Med; 2013 Aug; 14(7):430-6. PubMed ID: 23461846
[TBL] [Abstract][Full Text] [Related]
20. Strategies to manage hepatitis C virus (HCV) disease burden.
Wedemeyer H; Duberg AS; Buti M; Rosenberg WM; Frankova S; Esmat G; Örmeci N; Van Vlierberghe H; Gschwantler M; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HS; Cornberg M; Cramp ME; Dore GJ; Doss W; El-Sayed MH; Ergör G; Estes C; Falconer K; Félix J; Ferraz ML; Ferreira PR; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Guimarães Pessôa M; Hézode C; Hindman SJ; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KD; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marinho RT; Marotta P; Mauss S; Mendes Correa MC; Moreno C; Müllhaupt B; Myers RP; Nemecek V; Øvrehus AL; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Sarrazin C; Semela D; Sherman M; Shiha GE; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Vandijck D; Vogel W; Waked I; Weis N; Wiegand J; Yosry A; Zekry A; Negro F; Sievert W; Gower E
J Viral Hepat; 2014 May; 21 Suppl 1():60-89. PubMed ID: 24713006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
